08:56 AM EST, 01/28/2025 (MT Newswires) -- Health care stocks were steady pre-bell Tuesday, with the iShares Biotechnology ETF (IBB) inactive and The Health Care Select Sector SPDR Fund (XLV) marginally lower.

Apellis Pharmaceuticals ( APLS ) shares were down more than 2% even after the company said Australia's Therapeutic Goods Administration approved Syfovre for the every-other-month treatment of geographic atrophy in adults with age-related macular degeneration resulting in vision loss.